Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)
CNY 13.74
(3.85%)
CNY 13.74
(3.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 342.7 Million CNY | -35.71% |
| 2022 | 584.18 Million CNY | 24.5% |
| 2021 | 469.21 Million CNY | 7.84% |
| 2020 | 435.12 Million CNY | -3.86% |
| 2019 | 452.57 Million CNY | 63.7% |
| 2018 | 276.46 Million CNY | 34.04% |
| 2017 | 206.25 Million CNY | -4.77% |
| 2016 | 216.57 Million CNY | 10.11% |
| 2015 | 196.69 Million CNY | -6.4% |
| 2014 | 210.15 Million CNY | 21.75% |
| 2013 | 172.61 Million CNY | 7.61% |
| 2012 | 160.41 Million CNY | 1.11% |
| 2011 | 158.65 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 118.86 Million CNY | 46.29% |
| 2024 Q1 | 95.23 Million CNY | 28.74% |
| 2024 Q2 | 84.17 Million CNY | -11.62% |
| 2023 Q1 | 77.23 Million CNY | -5.12% |
| 2023 Q4 | 73.97 Million CNY | -40.78% |
| 2023 Q3 | 124.91 Million CNY | 25.62% |
| 2023 Q2 | 99.43 Million CNY | 28.75% |
| 2023 FY | 375.56 Million CNY | -35.71% |
| 2022 Q4 | 81.4 Million CNY | -34.13% |
| 2022 Q3 | 123.58 Million CNY | -30.04% |
| 2022 Q1 | 202.53 Million CNY | 55.83% |
| 2022 Q2 | 176.65 Million CNY | -12.78% |
| 2022 FY | 584.18 Million CNY | 24.5% |
| 2021 Q4 | 129.96 Million CNY | 56.97% |
| 2021 Q2 | 138.11 Million CNY | 16.72% |
| 2021 Q1 | 118.33 Million CNY | 54.55% |
| 2021 FY | 469.21 Million CNY | 7.84% |
| 2021 Q3 | 82.79 Million CNY | -40.05% |
| 2020 Q1 | 100.31 Million CNY | -25.26% |
| 2020 Q4 | 76.56 Million CNY | -29.45% |
| 2020 Q3 | 108.52 Million CNY | -27.51% |
| 2020 Q2 | 149.72 Million CNY | 49.26% |
| 2020 FY | 435.12 Million CNY | -3.86% |
| 2019 FY | 452.57 Million CNY | 63.7% |
| 2019 Q1 | 96.68 Million CNY | -12.85% |
| 2019 Q2 | 107.56 Million CNY | 11.25% |
| 2019 Q3 | 114.11 Million CNY | 6.09% |
| 2019 Q4 | 134.21 Million CNY | 17.62% |
| 2018 FY | 276.46 Million CNY | 34.04% |
| 2018 Q4 | 110.93 Million CNY | 60.08% |
| 2018 Q3 | 69.3 Million CNY | 25.77% |
| 2018 Q2 | 55.09 Million CNY | 33.99% |
| 2018 Q1 | 41.12 Million CNY | -32.89% |
| 2017 FY | 206.25 Million CNY | -4.77% |
| 2017 Q1 | 51.58 Million CNY | -3.34% |
| 2017 Q4 | 61.27 Million CNY | 69.12% |
| 2017 Q3 | 36.23 Million CNY | -36.63% |
| 2017 Q2 | 57.16 Million CNY | 10.82% |
| 2016 Q1 | 43.99 Million CNY | 0.0% |
| 2016 Q4 | 53.36 Million CNY | 6.05% |
| 2016 Q3 | 50.32 Million CNY | -26.96% |
| 2016 FY | 216.57 Million CNY | 10.11% |
| 2016 Q2 | 68.89 Million CNY | 56.62% |
| 2015 FY | 196.69 Million CNY | -6.4% |
| 2014 Q2 | 46.77 Million CNY | 0.0% |
| 2014 Q1 | 46.77 Million CNY | 0.0% |
| 2014 FY | 210.15 Million CNY | 21.75% |
| 2013 FY | 172.61 Million CNY | 7.61% |
| 2012 FY | 160.41 Million CNY | 1.11% |
| 2011 FY | 158.65 Million CNY | 0.0% |